Welcome to LookChem.com Sign In|Join Free

CAS

  • or

53152-21-9

Post Buying Request

53152-21-9 Suppliers

Recommended suppliersmore

This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.

53152-21-9 Usage

Description

Buprenorphine Hydrochloride is a certified reference material and an opioid that functions as a partial agonist of the μ-opioid receptor. It also acts, though less potently, at δand κ-opioid receptors. Buprenorphine is utilized in the treatment of opiate addiction, either alone or in combination with naloxone. It is available under the brand names Buprenex and Subutex and is intended for research and forensic applications.

Uses

Used in Pharmaceutical Industry:
Buprenorphine Hydrochloride is used as an active pharmaceutical ingredient for the treatment of opiate addiction. It acts as a partial agonist of the μ-opioid receptor, providing relief from withdrawal symptoms and reducing cravings for opioids.
Used in Research and Forensic Applications:
Buprenorphine Hydrochloride is used as a certified reference material in research and forensic applications. It helps in the development and validation of analytical methods, ensuring the accuracy and reliability of test results in various scientific and legal contexts.

Acquired resistance

Buprenorphine is 20 to 50 times more potent than morphine in producing an ED50 analgesic effect in animal studies; however, it cannot produce an ED100 (compared to morphine) in these tests. Thus, buprenorphine is a potent partial agonist at μ opioid receptors. It also is a partial agonist at κreceptors but more of an antagonist at δ receptors. Buprenorphine, at 0.4 mg intramuscular dose, will produce the same degree of analgesia as 10 mg of morphine. Because of its partial agonist properties, it has a lower ceiling on its analgesic action but also produces less severe respiratory depression. It is incapable of producing tolerance and addiction comparable to full μ agonists. In fact, buprenorphine's partial agonist action, very high affinity for opioid receptors, and high lipophilicity combine to give buprenorphine a tolerance, addiction, and withdrawal profile that is unique among the opioids. When given by itself to opioid-naive patients, little tolerance or addictive potential (Schedule 5) is observed. A mild withdrawal can occur some 2 weeks after the last dose of buprenorphine. Buprenorphine will precipitate withdrawal symptoms in highly addicted individuals, but it will suppress symptoms in individuals who are undergoing withdrawal from opioids. It effectively blocks the effect of high doses of heroin. Because of these properties, buprenorphine has been approved for office-based use in treating opioid dependence. It also has been reported to suppress cocaine use and addiction.

Biological Activity

ORL 1 receptor agonist that also displays mixed antagonist/partial agonist activity at κ , δ and μ -opioid receptors.

Biochem/physiol Actions

Full agonist at ORL1 receptors, antagonist or partial agonist at μ, κ, and δ opioid receptors.

Clinical Use

Buprenorphine undergoes extensive first-pass 3-O-glucuronidation, which negates its usefulness after oral dose. It is available in parenteral and sublingual dosage forms. The typical dose is 0.3 to 0.6 mg three times per day by intramuscular injection for analgesia or 8 mg/day as a sublingual tablet for opioid-dependence maintenance. The duration of analgesic effect is 4 to 6 hours. After parenteral dose, approximately 70% of the drug is excreted in the feces, and the remainder appears as N-dealkylated and conjugated metabolites in the urine. Naloxone is not an effective antagonist to buprenorphine because of the latter's high binding affinity to opioid receptors.

Check Digit Verification of cas no

The CAS Registry Mumber 53152-21-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,3,1,5 and 2 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 53152-21:
(7*5)+(6*3)+(5*1)+(4*5)+(3*2)+(2*2)+(1*1)=89
89 % 10 = 9
So 53152-21-9 is a valid CAS Registry Number.
InChI:InChI=1/C29H41NO4.ClH/c1-25(2,3)26(4,32)20-15-27-10-11-29(20,33-5)24-28(27)12-13-30(16-17-6-7-17)21(27)14-18-8-9-19(31)23(34-24)22(18)28;/h8-9,17,20-21,24,31-32H,6-7,10-16H2,1-5H3;1H/t20-,21-,24-,26+,27-,28+,29-;/m1./s1

53152-21-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name buprenorphine hydrochlorie

1.2 Other means of identification

Product number -
Other names Buprenorphine Hcl

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:53152-21-9 SDS

53152-21-9Upstream product

53152-21-9Downstream Products